Microbiological and serological diagnosis of pertussis

Clinical Infectious Diseases

Volumn 28, Issue 6 SUPPL. 2, 1999, Pages

  Hallander, Hans O ^a  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CATION EXCHANGE RESIN; HEMAGGLUTININ; IMMUNOGLOBULIN ANTIBODY; PERTUSSIS TOXIN;

BACTERIUM CULTURE; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; PERTUSSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERODIAGNOSIS;

EID: 0033046289     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515056     Document Type: Conference Paper

References (35)

1. 1. Isacson J, Trollfors B, Taranger J, Zackrisson G, Lagergård T. How common is whooping cough in a nonvaccinating country? Pediatr Infect Dis J 1993;12:284-8.
2. 2. von König CHW, Rott H, Bogaerts H, Schmitt HJ. A serological study of organisms possibly associated with pertussis-like coughing. Pediatr Infect Dis J 1998;17:645-9.
3. 3. Hallander HO, Reizenstein E, Renemar B, Rasmusson G, Mardin L, Olin P. Comparison of nasopharyngeal aspirates with swabs for culture of Bordetella pertussis. J Clin Microbiol 1993;31:50-2.
4. 4. Regan J, Lowe F. Enrichment medium for the isolation of Bordetella. J Clin Microbiol 1977;6:303-9.
5. 5. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. Efficacy trial of acellular pertussis vaccines. Technical report, trial I. SMI-tryck (Swedish Institute for Infectious Disease Control, Stockholm) 1995; 105:1-70.
6. 6. Heininger U, Klemens S, Schmitt-Grohe S, et al. Clinical characteristics of Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J 1994;13:306-9.
7. 7. Mastrantonio P, Stefanelli P, Giuliano M, et al. Bordetella parapertussis infection in children: epidemiology, clinical symptoms, and molecular characteristics of isolates, J Clin Microbiol 1998;36:999-1002.
8. 8. Lautrop H, Lacey BW, Laboratory diagnosis of whooping-cough or Bordetella infections. Bull World Health Organ 1960;23:15-35.
9. 9. Müller F-MC, Hoppe JE, Wirsing von König C-H. Laboratory diagnosis of pertussis: slate of the art in 1997. J Clin Microbiol 1997;35: 2435-43.
10. 10. Gustafson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular and a whole-cell pertussis vaccine. N Engl J Med 1996;334:349-55.
11. 11. Gilligan PH, Fisher MC. Importance of culture in laboratory diagnosis of Bordetella pertussis infections. J Clin Microbiol 1984;20:891-3.
12. 12. Strebel PM, Cochi SL, Farizo KM, Payne BJ, Hanauer SD, Baughman AL. Pertussis in Missouri: evaluation of nasopharyngeal culture, direct fluorescent antibody testing, and clinical case definitions in the diagnosis of pertussis. Clin Infect Dis 1993;16:276-85.
13. 13. McNicol P, Giercke SM, Gray M, et al. Evaluation and validation of a monoclonal immunofluorescent reagent for direct detection of Bordetella pertussis. J Clin Microbiol 1995;33:2868-71.
14. 14. Glare EM, Paton JC, Premier RR, Lawrence AJ, Nisbet IT. Analysis of a repetitive DNA sequence from Bordetella pertussis and its application to the diagnosis of pertussis using the polymerase chain reaction. J Clin Microbiol 1990;28:1982-7.
15. 15. Houard S, Hackel C, Herzog A, Bollen A. Specific identification of Bordetella pertussis by the polymerase chain reaction. Res Microbiol 1989; 140:477-87.
16. 16. Douglas E, Coote JG, Parton R, McPheat W. Identification of Bordetella pertussis in nasopharyngeal swabs by PCR amplification of a region of the adenylate cyclase gene. J Med Microbiol 1993;38:140-4.
17. 17. Li Z, Jansen DL, Finn TM, et al. Identification of Bordetella pertussis by shared-primer PCR. J Clin Microbiol 1994;32:783-9.
18. 18. Meade BD, Bollen A. Recommendations for use of the polymerase chain reaction in the diagnosis of Bordetella pertussis infections. J Med Microbiol 1994;41:51-5.
19. 19. Reizenstein E. Diagnostic polymerase chain reaction in pertussis vaccine trials. Dev Biol Stand 1997;89:247-54.
20. 20. Reizenstein E, Lindberg L, Möllby R, Hallander HO. Validation of nested Bordetella PCR in pertussis vaccine trial. J Clin Microbiol 1996;34: 810-5.
21. 21. Buck GE. Detection of Bordetella pertussis by rapid-cycle PCR and colorimetric microwell hybridization. J Clin Microbiol 1996;34:1355-8.
22. 22. Nelson S, Matlow A, McDowell C, et al. Detection of Bordetella pertussis in clinical specimens by PCR and a microtiter plate-based DNA hybridization assay. J Clin Microbiol 1997;35:117-20.
23. 23. Wadowsky RM, Michaels RH, Libert T, Kingsley LA, Ehrlich GD. Multiplex PCR-based assay for detection of Bordetella pertussis in nasopharyngeal swab specimens. J Clin Microbiol 1996;34:2645-9.
24. 24. Hallander HO. Diagnostic pertussis serology in the recent clinical efficacy studies of acellular vaccines. Dev Biol Stand 1997;89:205-12.
25. 25. Meade BD, Deforest A, Edwards KM, et al. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics 1995;96:S570-5.
26. 26. Lynn F, Reed GF, Meade BD. Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens: quantitative agreement. Clin Diagn Lab Immunol 1996;3:689-700.
27. 27. Reizenstein E, Hallander HO, Blackwelder WC, Kühn I, Ljungman M, Möllby R. Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model. J Immunol Methods 1995;183:279-90.
28. 28. Hallander HO, Reizenstein E. Immunogenicity of acellular pertussis vaccines. Biologicals 1994;22:391-5.
29. 29. Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of antipertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 1998;16:1907-16.
30. 30. Tiru M, Askelöf P, Granström M, Hallander HO. Bordetella pertussis serotype of clinical isolates in Sweden during 1970-1995 and influence of vaccine efficacy studies. Dev Biol Stand 1997;89:239-45.
31. 31. Preston NW. Essential immunogens in human pertussis: the role of fimbriae. Dev Biol Stand 1983;51:137-41.
32. 32. Mooi FR, van Oirschot H, Heuvelman K, van der Heide H, Gaastra W, Willems RJL. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in the Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun 1998; 66:670-5.
33. 33. De Moissac YR, Ronald SL, Peppler MS. Use of pulsed-field gel electrophoresis for epidemiological study of Bordetella pertussis in a whooping cough outbreak. J Clin Microbiol 1994;32:398-402.
34. 34. Beall B, Cassiday PK, Sanden GN. Analysis of Bordetella pertussis from an epidemic by pulsed-field gel electrophoresis. J Clin Microbiol 1995; 33:3083-6.
35. 35. Olin P, Rasmussen F, Gustafsson L, Hallander HO, Heijbel H. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Lancet 1997;350:1569-77.